These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30901632)

  • 1. The intersection of sex and gender in the treatment of influenza.
    Morgan R; Klein SL
    Curr Opin Virol; 2019 Apr; 35():35-41. PubMed ID: 30901632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex and sex steroids impact influenza pathogenesis across the life course.
    Vom Steeg LG; Klein SL
    Semin Immunopathol; 2019 Mar; 41(2):189-194. PubMed ID: 30298431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical need for new antiviral drugs directed against influenza virus.
    McCullers JA
    J Infect Dis; 2006 Mar; 193(6):751-3. PubMed ID: 16479505
    [No Abstract]   [Full Text] [Related]  

  • 4. Influenza: emergence and control.
    Lipatov AS; Govorkova EA; Webby RJ; Ozaki H; Peiris M; Guan Y; Poon L; Webster RG
    J Virol; 2004 Sep; 78(17):8951-9. PubMed ID: 15308692
    [No Abstract]   [Full Text] [Related]  

  • 5. Perspective of Use of Antiviral Peptides against Influenza Virus.
    Skalickova S; Heger Z; Krejcova L; Pekarik V; Bastl K; Janda J; Kostolansky F; Vareckova E; Zitka O; Adam V; Kizek R
    Viruses; 2015 Oct; 7(10):5428-42. PubMed ID: 26492266
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Hughes HR; Brockmeier SL; Loving CL
    Front Immunol; 2018; 9():2255. PubMed ID: 30337924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models.
    Fukao K; Ando Y; Noshi T; Kitano M; Noda T; Kawai M; Yoshida R; Sato A; Shishido T; Naito A
    PLoS One; 2019; 14(5):e0217307. PubMed ID: 31107922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza viruses: basic biology and potential drug targets.
    Basler CF
    Infect Disord Drug Targets; 2007 Dec; 7(4):282-93. PubMed ID: 18220960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vaccines and chemicals for the prevention of influenza].
    Gendon IuZ
    Vopr Virusol; 2007; 52(1):4-10. PubMed ID: 17338227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-influenza Activity of a Bacillus subtilis Probiotic Strain.
    Starosila D; Rybalko S; Varbanetz L; Ivanskaya N; Sorokulova I
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28416546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza, a One Health paradigm--novel therapeutic strategies to fight a zoonotic pathogen with pandemic potential.
    Ludwig S; Zell R; Schwemmle M; Herold S
    Int J Med Microbiol; 2014 Oct; 304(7):894-901. PubMed ID: 25220817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza: girding for disaster. Searching for all-powerful flu weapons.
    Kaiser J
    Science; 2004 Oct; 306(5695):395. PubMed ID: 15486268
    [No Abstract]   [Full Text] [Related]  

  • 13. Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses.
    Sullivan C; Jurcyzszak D; Goody MF; Gabor KA; Longfellow JR; Millard PJ; Kim CH
    J Vis Exp; 2017 Jan; (119):. PubMed ID: 28190053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidyl Inositol 3 Kinase-Gamma Balances Antiviral and Inflammatory Responses During Influenza A H1N1 Infection: From Murine Model to Genetic Association in Patients.
    Garcia CC; Tavares LP; Dias ACF; Kehdy F; Alvarado-Arnez LE; Queiroz-Junior CM; Galvão I; Lima BH; Matos AR; Gonçalves APF; Soriani FM; Moraes MO; Marques JT; Siqueira MM; Machado AMV; Sousa LP; Russo RC; Teixeira MM
    Front Immunol; 2018; 9():975. PubMed ID: 29867955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral role of toll-like receptor-3 agonists against seasonal and avian influenza viruses.
    Wong JP; Christopher ME; Viswanathan S; Dai X; Salazar AM; Sun LQ; Wang M
    Curr Pharm Des; 2009; 15(11):1269-74. PubMed ID: 19355966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathological effects of CCR2+ inflammatory monocytes are amplified by an IFNAR1-triggered chemokine feedback loop in highly pathogenic influenza infection.
    Lin SJ; Lo M; Kuo RL; Shih SR; Ojcius DM; Lu J; Lee CK; Chen HC; Lin MY; Leu CM; Lin CN; Tsai CH
    J Biomed Sci; 2014 Nov; 21(1):99. PubMed ID: 25407417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccination for healthy children.
    Glezen WP
    Curr Opin Infect Dis; 2002 Jun; 15(3):283-7. PubMed ID: 12015463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New drug-strategies to tackle viral-host interactions for the treatment of influenza virus infections.
    van de Wakker SI; Fischer MJE; Oosting RS
    Eur J Pharmacol; 2017 Aug; 809():178-190. PubMed ID: 28533172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of sex disparities in influenza pathogenesis.
    Klein SL; Hodgson A; Robinson DP
    J Leukoc Biol; 2012 Jul; 92(1):67-73. PubMed ID: 22131346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches for the control of influenza.
    Woodland DL
    Viral Immunol; 2012 Feb; 25(1):1-2. PubMed ID: 22239236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.